GDBspace, a Space Pharmaceuticals company, selected among 10 Swiss scale-up companies to join the Venture Kick Scale Up Bootcamp
GDBspace, a Space Pharmaceuticals company specialized in computational methods for drug discovery, was selected by the Venture Kick jury, to join the Venture Kick Scale Up Bootcamp among 10 Swiss scale-up companies. The Swiss companies selected are: Lino Biotech, Galventa, Alithea Genomics, Resistell, Oncobit, Healiva, GDBspace, FluoSphera, Recolony and Alithea Genomics. Dr. Jingwen Shi, CBO […]
We are pleased to welcome Dr. Kapila Gunasekera as Senior Computational Chemist. Dr. Gunasekera is a molecular biology and computational biology scientist with experience spanning from biology to genetics, bioinformatics and peptide chemistry, as well as a track records of excellent publications. At GDBspace, Dr. Kapila Gunasekera will work on computational peptide design.
Space Pharmaceuticals, an AI-driven chemical space drug discovery company based in Basel, Switzerland, announced the completion of a Series A financing round of CHF 12 million, led by Venture Capital firm Cowin Capital. Spinned-off from 20 years of computational chemistry research from Prof. Jean-Louis Reymond, University of Bern, Switzerland, Space Pharmaceuticals’ GDBspace drug discovery engine […]
Space Pharmaceuticals is pleased to welcome Dr. Simon Nebel as Business Advisor. Dr. Simon Nebel has participated in the financing of a number of life science companies and the M&A transactions for Aravis portfolio companies. He has been the board member or observer in fourteen companies. Before joining Aravis, he was a group strategist at […]
Space Pharmaceuticals is pleased to welcome Prof. Hans-Joachim Böhm as Scientific advisor. Prof. Hans-Joachim Böhm is a professor of Bioinformatics at the University of Basel, working on the development of new methods for computer-aided drug design, as well as a member of the Swiss Science Council. He worked for several years at Roche in both […]
GDBspace, a Space Pharmaceuticals company, announces exclusive collaboration and licensing agreement with Sinqi Pharmaceutical to discover and develop novel ophthalmology therapies
GDBspace, a Space Pharmaceuticals company specialized in chemical space-based drug discovery, and Sinqi Pharmaceutical, a leading ophthalmology pharmaceutical company, announced today an exclusive global collaboration and licensing agreement to research, develop, manufacture and commercialize novel peptide drugs of an undisclosed ophthalmology target. “Space Pharmaceuticals is rooted in a long history of computational chemistry research and […]
GDBspace, a Space Pharmaceuticals company, extends its strategic collaboration with the University of Bern, Switzerland, to the next 5 years
GDBspace, a Space Pharmaceuticals company, announces that it decided to extend its collaboration with the University of Bern, Switzerland, for the next 5 years, aiming to continue to build on the success of the precedent years of successfully accelerating translational research projects as well as building a strong cohort of scientists with in-depth knowledge of AI-based drug discovery from both […]
GDBspace, a Space Pharmaceuticals company, selected among 10 Swiss innovative companies to represent Swiss innovations in the USA
GDBspace AG, a Swiss company specializing in computational methods for molecule discovery, was selected by the Swiss Innovation Council, together with Swissnex, to represent Swiss innovations in the USA and obtained related suppport for market entry into the US market.
GDBspace, a Space Pharmaceuticals company, signs a software license agreement with a world leading pharmaceutical company
GDBspace AG, a company specializing in computational methods for molecule discovery, today signs a software license agreement with a leading pharmaceutical company to support its molecule screening activities.
GDBspace AG, a company specializing in computational methods for molecule discovery, discusses a novel cheminformatics approach for drug discovery, in Drug Target Review, Volume 7, Issue 02, Summer 2020.